The estimated Net Worth of John Edward Adent is at least $4.75 Million dollars as of 25 April 2024. Mr. Adent owns over 2,113 units of Neogen stock worth over $2,622,680 and over the last 9 years he sold NEOG stock worth over $0. In addition, he makes $2,123,450 as President, Chief Executive Officer und Director at Neogen.
Sign up
Mr. Adent NEOG stock SEC Form 4 insiders trading
John has made over 12 trades of the Neogen stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 2,113 units of NEOG stock worth $25,271 on 25 April 2024.
The largest trade he's ever made was exercising 40,464 units of Neogen stock on 31 March 2021 worth over $2,554,492. On average, John trades about 6,248 units every 62 days since 2016. As of 25 April 2024 he still owns at least 171,979 units of Neogen stock.
You can see the complete history of Mr. Adent stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Adent biography
John Edward Adent serves as President, Chief Executive Officer, Director of the Company. Mr. Adent joined Neogen as Chief Executive Officer on July 17, 2017. Prior to joining Neogen, Mr. Adent served as the Chief Executive Officer of Animal Health International, Inc., formerly known as Lextron, Inc., from 2004 to 2015, also serving as its President during that time. Animal Health International was sold to Patterson Companies, Inc. in 2015, and Mr. Adent served as the Chief Executive Officer of the $3.3 billion Animal Health Division of Patterson Animal Health from that period until his resignation on July 1, 2017. Mr. Adent began his career with management responsibilities for Ralston Purina Company, developing animal feed manufacturing and sales operations in China and the Philippines. When Ralston Purina spun off that business to Agribrands, he continued his management role in the European division in Spain and Hungary, serving as managing director of the Hungarian operations. He left Ralston Purina in 2004.
What is the salary of John Adent?
As the President, Chief Executive Officer und Director of Neogen, the total compensation of John Adent at Neogen is $2,123,450. There are no executives at Neogen getting paid more.
How old is John Adent?
John Adent is 52, he's been the President, Chief Executive Officer und Director of Neogen since 2019. There are 10 older and 4 younger executives at Neogen. The oldest executive at Neogen Corp. is G. Bruce Papesh, 73, who is the Independent Director.
What's John Adent's mailing address?
John's mailing address filed with the SEC is Neogen, 620, Lesher Place, Oak Park, Lansing, Ingham County, Michigan, 48912, United States.
Insiders trading at Neogen
Over the last 24 years, insiders at Neogen have traded over $135,917,555 worth of Neogen stock and bought 195,554 units worth $4,379,833 . The most active insiders traders include James L Herbert, Jeffrey D Capello und Lon M Bohannon. On average, Neogen executives and independent directors trade stock every 11 days with the average trade being worth of $140,346. The most recent stock trade was executed by Ronald D Green on 29 August 2024, trading 4,446 units of NEOG stock currently worth $68,780.
What does Neogen do?
neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.
What does Neogen's logo look like?
Complete history of Mr. Adent stock trades at Neogen und Patterson Companies
Neogen executives and stock owners
Neogen executives and other stock owners filed with the SEC include:
-
John Adent,
President, Chief Executive Officer, Director -
Steven Quinlan,
Chief Financial Officer, Vice President, Secretary -
John Edward Adent,
Pres, CEO & Director -
Jason Lilly,
Vice President - International Business -
Jerome Hagedorn,
Vice President - Food Safety operations -
Douglas E. Jones,
VP & Chief Commercial Officer -
Steven J. Quinlan,
VP & CFO -
James Borel,
Lead Independent Chairman of the Board -
James Tobin,
Independent Director -
Ronald Green,
Independent Director -
William Boehm,
Independent Director -
Darci Vetter,
Independent Director -
G. Bruce Papesh,
Independent Director -
Doug Jones,
Chief Commercial Officer -
Amy M. Rocklin Ph.D.,
VP, Gen. Counsel & Corp. Sec. -
Julie A. Mann,
VP & Chief HR Officer -
Rod Poland,
Director of Corp. Communications -
Amy Rocklin Ph.D.,
VP & Gen. Counsel -
Sarah Demey,
Admin. Mang. -
Bruce Papesh,
Director -
A Charles Fischer,
Director -
Richard E Jr Calk,
President & COO -
Richard T Crowder,
Director -
Jack C Parnell,
Director -
Clayton K Yeutter,
Director -
Thomas H Reed,
Director -
Terri A Morrical,
-
David H. Naemura,
Chief Financial Officer -
Edward Bradley,
V.P. Sales and Marketing -
Aashima Gupta,
Director -
Jeffrey D Capello,
Director -
Rex L Hamilton,
Vice President -
Herbert D Doan,
Director -
Gordon E Guyer,
Director -
James L Herbert,
Director -
Joseph M Madden,
V.P. Scientific Affairs -
Richard R Current,
Vice President & CFO -
Anthony E Maltese,
VP Business Development -
Kenneth V Kodilla,
Vice President -
Lon M Bohannon,
COO -
Mark A Mozola,
Vice President of R&D -
Leonard E Heller,
Director -
Robert M Book,
Director -
Stephen K. Snyder,
Former Pres. and COO -
Paul S Satoh,
V.P Research and Development -
Rafael A Rodriguez,
Director -
Catherine E Woteki,
Director -
Amy M Rocklin,
Chief Legal Officer -
John Patrick Moylan,
Chief Accounting Officer